FDA Inspection
Baxalta US Inc.Baxalta US Inc. – FDA Inspection, Mar 2, 2018
Record Details
This FDA Inspection record concerns Baxalta US Inc., with an inspection on March 2, 2018, issued by the Atlanta District Office, covering biologics.
- Office
- Atlanta District Office
- People
- Deborah M. Trout (Issuing Officer)
- Lily Y. Koo (Issuing Officer)
- Michael C. Kennedy (Issuing Officer)
- Omotunde O. Osunsanmi (Issuing Officer)
- Silvia Wanis (Issuing Officer)
- Yonggang Wang (Company Rep)
View Company Profile
ID · 7527e50d-1d45-486c-8d92-29a313ee4514
Inspection Facts
- Inspection number
- 1052376
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Baxalta US Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2025 | Not classified | Atlanta District Office | |
| July 1, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxalta US Inc.
- FDA Inspection 1257940 - 2025-01-30
- FDA Inspection 1146227 - 2021-07-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.